세계의 화학요법 시장 보고서(2023년)

“Chemotherapy Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on chemotherapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for chemotherapy? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The chemotherapy market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Product Type: Pump; Cannula; Catheter; Other Product Types

• 2) By Service: Blood Cancer; Throat Cancer; Lung Cancer; Ovarian Cancer; Stomach Cancer

• 3) By Drugs: Alkylating Agents; Antimetabolites; Anti-Tumor Antibiotics; Topoisomerase Inhibitors; Mitotic Inhibitors; Other Drugs

• 4) By Route Of Administration: Oral; Intravenous

• 5) By End User: Hospitals; Research Institutes; Other End Users

• Companies Mentioned: GlaxoSmithKline PLC; Eli Lilly and Company; F. Hoffmann-La Roche Ltd.; Novartis AG; Pfizer Inc.

• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

• Time series: Five years historic and ten years forecast.

• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the chemotherapy market are GlaxoSmithKline PLC, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer Inc., Merck & Co Inc., Sanofi S A, Celgene Corporation, Bristol-Myers Squibb Company, Amgen Inc., Bayer AG, Almatic Pharma LLC, AstraZeneca Pharmaceuticals, Astellas Pharma Inc., Puma Biotechnology Inc., Clovis Oncology, Takeda Pharmaceutical Company Limited, and Johnson & Johnson Services Inc .

The global chemotherapy market is expected to grow from $8.22 billion in 2022 to $8.94 billion in 2023 at a compound annual growth rate (CAGR) of 8.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The chemotherapy market is expected to reach $12.08 billion in 2027 at a CAGR of 7.8%.

The chemotherapy market includes revenues earned by entities by providing corticosteroids and hormonal agents as chemotherapy drugs. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

Chemotherapy refers to a treatment using drugs or medicines that kill the fast-growing cells in the body by using powerful chemicals. The drugs can be used in combination or alone for the treatment of cancer. They are used to treat cancer, as cancer cells grow at a fast rate.

North America was the largest region in the chemotherapy market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The main product types of chemotherapy are pumps, cannulas, catheters, and other types. Pumps are chemotherapy infusion pumps that are attached to the patient and deliver a controlled number of drugs slowly into the patient's bloodstream. The main services involved are blood cancer, throat cancer, lung cancer, ovarian cancer, and stomach cancer by using alkylating agents, antimetabolites, anti-tumor antibiotics, topoisomerase inhibitors, mitotic inhibitors, and other drugs that are delivered through oral and intravenous routes and are used in end-users such as hospitals, research institutes, and other end-users.

The increasing cancer prevalence is expected to propel the growth of the chemotherapy market going forward. Cancer refers to a disease in which a few body cells grow uncontrollably and spread to other parts. In chemotherapy powerful chemicals are used in combination or alone for the treatment of cancer by killing fast-growing cancer cells. In addition, increasing cancer prevalence will increase the demand for chemotherapy. For instance, according to Globocan, a Switzerland-based provider of a worldwide database of cancer prevalence and mortality rates, in 2020 there were around 19.29 million new cancer cases globally, and the number of cancer cases in 5 years is estimated to be 50.55 million. Therefore, the increasing cancer prevalence is driving the chemotherapy market.

Innovative technology development is a key trend gaining popularity in the chemotherapy market. Major companies operating in the chemotherapy market are focused on developing new technological solutions such as using artificial intelligence and nanotechnology for real-time tracking and treatment to strengthen their position in the market. For instance, in October 2020, ImpriMed, Inc., a US-based company that provides cutting-edge personalized medicine for pets with blood cancer diseases, launched a cutting-edge technology called "SDM4", an AI-based chemotherapy predictive system for lymphoma. The technology is uniquely designed for chemotherapy-sensitive assays via artificial intelligence (AI), which are optimized to give higher sensitivity and specificity, as well as a high positive predictive value, in just 7 days. By collecting a sample with fine needle aspiration, this technology aids in determining the type of lymphoma cancer.

In October 2021, Amgen Inc., a US-based global biotechnology company, acquired ChemoCentryx Inc. for $3.7 billion. The acquisition is expected to enhance Amgen's inflammation and nephrology portfolios by adding ChemoCentryx's TAVNEOS®. With the acquisition, the companies are expected to be involved in expanding and innovating advanced treatments to serve patients affected by serious diseases. ChemoCentryx, Inc., is a US-based biopharmaceutical company that treats autoimmune diseases, inflammatory disorders, and cancer.

The countries covered in the chemotherapy market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The chemotherapy market research report is one of a series of new reports from The Business Research Company that provides chemotherapy optical components market statistics, including chemotherapy optical components industry global market size, regional shares, competitors with a chemotherapy optical components market share, detailed chemotherapy optical components market segments, market trends and opportunities, and any further data you may need to thrive in the chemotherapy optical components industry. This chemotherapy optical components market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Table of Contents

1. Executive Summary

2. Chemotherapy Market Characteristics

3. Chemotherapy Market Trends And Strategies

4. Chemotherapy Market - Macro Economic Scenario

• 4.1. COVID-19 Impact On Chemotherapy Market
• 4.2. Ukraine-Russia War Impact On Chemotherapy Market
• 4.3. Impact Of High Inflation On Chemotherapy Market

5. Chemotherapy Market Size And Growth

• 5.1. Global Chemotherapy Historic Market, 2017-2022, $ Billion
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints On The Market
• 5.2. Global Chemotherapy Forecast Market, 2022-2027F, 2032F, $ Billion
  • 5.2.1. Drivers Of The Market
  • 5.2.2. Restraints On the Market

6. Chemotherapy Market Segmentation

• 6.1. Global Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Pump
• Cannula
• Catheter
• Other Product Types
• 6.2. Global Chemotherapy Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Blood Cancer
• Throat Cancer
• Lung Cancer
• Ovarian Cancer
• Stomach Cancer
• 6.3. Global Chemotherapy Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Alkylating Agents
• Antimetabolites
• Anti-Tumor Antibiotics
• Topoisomerase Inhibitors
• Mitotic Inhibitors
• Other Drugs
• 6.4. Global Chemotherapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Oral
• Intravenous
• 6.5. Global Chemotherapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Hospitals
• Research Institutes
• Other End Users

7. Chemotherapy Market Regional And Country Analysis

• 7.1. Global Chemotherapy Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 7.2. Global Chemotherapy Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific Chemotherapy Market

• 8.1. Asia-Pacific Chemotherapy Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 8.3. Asia-Pacific Chemotherapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China Chemotherapy Market

• 9.1. China Chemotherapy Market Overview
• 9.2. China Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
• 9.3. China Chemotherapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India Chemotherapy Market

• 10.1. India Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 10.2. India Chemotherapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan Chemotherapy Market

• 11.1. Japan Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 11.2. Japan Chemotherapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia Chemotherapy Market

• 12.1. Australia Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 12.2. Australia Chemotherapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia Chemotherapy Market

• 13.1. Indonesia Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 13.2. Indonesia Chemotherapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea Chemotherapy Market

• 14.1. South Korea Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 14.2. South Korea Chemotherapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe Chemotherapy Market

• 15.1. Western Europe Chemotherapy Market Overview
• 15.2. Western Europe Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 15.3. Western Europe Chemotherapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK Chemotherapy Market

• 16.1. UK Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 16.2. UK Chemotherapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany Chemotherapy Market

• 17.1. Germany Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 17.2. Germany Chemotherapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France Chemotherapy Market

• 18.1. France Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 18.2. France Chemotherapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe Chemotherapy Market

• 19.1. Eastern Europe Chemotherapy Market Overview
• 19.2. Eastern Europe Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 19.3. Eastern Europe Chemotherapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia Chemotherapy Market

• 20.1. Russia Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 20.2. Russia Chemotherapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America Chemotherapy Market

• 21.1. North America Chemotherapy Market Overview
• 21.2. North America Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 21.3. North America Chemotherapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA Chemotherapy Market

• 22.1. USA Chemotherapy Market Overview
• 22.2. USA Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 22.3. USA Chemotherapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America Chemotherapy Market

• 23.1. South America Chemotherapy Market Overview
• 23.2. South America Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 23.3. South America Chemotherapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil Chemotherapy Market

• 24.1. Brazil Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 24.2. Brazil Chemotherapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East Chemotherapy Market

• 25.1. Middle East Chemotherapy Market Overview
• 25.2. Middle East Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 25.3. Middle East Chemotherapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa Chemotherapy Market

• 26.1. Africa Chemotherapy Market Overview
• 26.2. Africa Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 26.3. Africa Chemotherapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. Chemotherapy Market Competitive Landscape And Company Profiles

• 27.1. Chemotherapy Market Competitive Landscape
• 27.2. Chemotherapy Market Company Profiles
  • 27.2.1. GlaxoSmithKline PLC
    • 27.2.1.1. Overview
    • 27.2.1.2. Products and Services
    • 27.2.1.3. Strategy
    • 27.2.1.4. Financial Performance
  • 27.2.2. Eli Lilly and Company
    • 27.2.2.1. Overview
    • 27.2.2.2. Products and Services
    • 27.2.2.3. Strategy
    • 27.2.2.4. Financial Performance
  • 27.2.3. F. Hoffmann-La Roche Ltd
    • 27.2.3.1. Overview
    • 27.2.3.2. Products and Services
    • 27.2.3.3. Strategy
    • 27.2.3.4. Financial Performance
  • 27.2.4. Novartis AG
    • 27.2.4.1. Overview
    • 27.2.4.2. Products and Services
    • 27.2.4.3. Strategy
    • 27.2.4.4. Financial Performance
  • 27.2.5. Pfizer Inc
    • 27.2.5.1. Overview
    • 27.2.5.2. Products and Services
    • 27.2.5.3. Strategy
    • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Chemotherapy Market

29. Chemotherapy Market Future Outlook and Potential Analysis

30. Appendix

• 30.1. Abbreviations
• 30.2. Currencies
• 30.3. Historic And Forecast Inflation Rates
• 30.4. Research Inquiries
• 30.5. The Business Research Company
• 30.6. Copyright And Disclaimer